Enterprise record

Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:ac77c5d8-2172-45a0-affc-bcebdd49c992Version: public-1As of: unavailable

15 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 30, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 30, 2026

    Supports 3 claims
    • Legal Name: Enliven Therapeutics, Inc. · Claim reviewed: Sep 30, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 30, 2026
    • Published Fact: US · Claim reviewed: Sep 30, 2026

  2. DEF 14A d948512ddef14a.htm

    sec proxy · Source published: Apr 27, 2026 · Retrieved: Sep 2, 2026

    Supports 7 claims
    • Leadership Role: Andrew Phillips: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Jake Bauer: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Lori Kunkel: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Mika Derynck: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Rahul Ballal: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Richard Heyman: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Rishi Gupta: Director · Claim reviewed: Sep 30, 2026

  3. SEC DEF 14A 0001193125-26-182045

    sec def 14a · Source published: Apr 27, 2026 · Retrieved: Sep 6, 2026

    Supports 5 claims
    • Leadership Role: Richard Fair: President, Chief Executive Officer and Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Scott Garland: Director · Claim reviewed: Sep 30, 2026
    • Leadership Role: Benjamin Hohl: Chief Financial Officer and Head of Corporate Development · Claim reviewed: Sep 30, 2026
    • Leadership Role: Helen Collins: Chief Medical Officer · Claim reviewed: Sep 30, 2026
    • Leadership Role: Richard Fair: President and Chief Executive Officer · Claim reviewed: Sep 30, 2026